221 related articles for article (PubMed ID: 37654195)
21. Diagnostic significance and clinical impact of quantitative assays for diagnosis of human cytomegalovirus infection/disease in immunocompromised patients.
Gerna G; Percivalle E; Baldanti F; Sarasini A; Zavattoni M; Furione M; Torsellini M; Revello MG
New Microbiol; 1998 Jul; 21(3):293-308. PubMed ID: 9699213
[TBL] [Abstract][Full Text] [Related]
22. Human cytomegalovirus DNA kinetics using a novel HCMV DNA quantitative assay in white blood cells of immunocompromised patients under Ganciclovir therapy.
Payan C; Veal N; Sarol L; Villarmé M; Ngohou C; Riberi P; François S; Ifrah N; Loison J; Chennebault JM; Pichard E; Kouyoumdjian S; Lunel F
J Virol Methods; 1997 Apr; 65(1):131-8. PubMed ID: 9128870
[TBL] [Abstract][Full Text] [Related]
23. Inconsistent responses of cytomegalovirus-specific T cells to pp65 and IE-1 versus infected dendritic cells in organ transplant recipients.
Lilleri D; Zelini P; Fornara C; Comolli G; Gerna G
Am J Transplant; 2007 Aug; 7(8):1997-2005. PubMed ID: 17617865
[TBL] [Abstract][Full Text] [Related]
24. Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab.
Dunn EF; Iida M; Myers RA; Campbell DA; Hintz KA; Armstrong EA; Li C; Wheeler DL
Oncogene; 2011 Feb; 30(5):561-74. PubMed ID: 20956938
[TBL] [Abstract][Full Text] [Related]
25. Heterogeneous EGFR gene copy number increase is common in colorectal cancer and defines response to anti-EGFR therapy.
Ålgars A; Avoranta T; Österlund P; Lintunen M; Sundström J; Jokilehto T; Ristimäki A; Ristamäki R; Carpén O
PLoS One; 2014; 9(6):e99590. PubMed ID: 24940619
[TBL] [Abstract][Full Text] [Related]
26. BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis.
Nam SK; Yun S; Koh J; Kwak Y; Seo AN; Park KU; Kim DW; Kang SB; Kim WH; Lee HS
PLoS One; 2016; 11(3):e0151865. PubMed ID: 26991109
[TBL] [Abstract][Full Text] [Related]
27. BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis?
Velho S; Moutinho C; Cirnes L; Albuquerque C; Hamelin R; Schmitt F; Carneiro F; Oliveira C; Seruca R
BMC Cancer; 2008 Sep; 8():255. PubMed ID: 18782444
[TBL] [Abstract][Full Text] [Related]
28. Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target.
Baryawno N; Rahbar A; Wolmer-Solberg N; Taher C; Odeberg J; Darabi A; Khan Z; Sveinbjörnsson B; FuskevÅg OM; Segerström L; Nordenskjöld M; Siesjö P; Kogner P; Johnsen JI; Söderberg-Nauclér C
J Clin Invest; 2011 Oct; 121(10):4043-55. PubMed ID: 21946257
[TBL] [Abstract][Full Text] [Related]
29. Cytomegalovirus infection in mesenchymal stem cells and their activation could be enhanced by nuclear factor-κB inhibitor pyrrolidinedithiocarbamate in vitro.
Wei G; Lin M; Cai Z; Huang H
Transplant Proc; 2011 Jun; 43(5):1944-9. PubMed ID: 21693305
[TBL] [Abstract][Full Text] [Related]
30. Human cytomegalovirus preferentially infects the neoplastic epithelium of colorectal cancer: a quantitative and histological analysis.
Chen HP; Jiang JK; Chen CY; Chou TY; Chen YC; Chang YT; Lin SF; Chan CH; Yang CY; Lin CH; Lin JK; Cho WL; Chan YJ
J Clin Virol; 2012 Jul; 54(3):240-4. PubMed ID: 22595308
[TBL] [Abstract][Full Text] [Related]
31. Human cytomegalovirus and mucoepidermoid carcinoma of salivary glands: cell-specific localization of active viral and oncogenic signaling proteins is confirmatory of a causal relationship.
Melnick M; Sedghizadeh PP; Allen CM; Jaskoll T
Exp Mol Pathol; 2012 Feb; 92(1):118-25. PubMed ID: 22101257
[TBL] [Abstract][Full Text] [Related]
32. Expression of Oncogenic Alleles Induces Multiple Blocks to Human Cytomegalovirus Infection.
Xu S; Schafer X; Munger J
J Virol; 2016 May; 90(9):4346-4356. PubMed ID: 26889030
[TBL] [Abstract][Full Text] [Related]
33. Human Cytomegalovirus Utilizes a Nontraditional Signal Transducer and Activator of Transcription 1 Activation Cascade via Signaling through Epidermal Growth Factor Receptor and Integrins To Efficiently Promote the Motility, Differentiation, and Polarization of Infected Monocytes.
Collins-McMillen D; Stevenson EV; Kim JH; Lee BJ; Cieply SJ; Nogalski MT; Chan GC; Frost RW; Spohn CR; Yurochko AD
J Virol; 2017 Dec; 91(24):. PubMed ID: 29021395
[TBL] [Abstract][Full Text] [Related]
34. Human cytomegalovirus latent infection alters the expression of cellular and viral microRNA.
Fu M; Gao Y; Zhou Q; Zhang Q; Peng Y; Tian K; Wang J; Zheng X
Gene; 2014 Feb; 536(2):272-8. PubMed ID: 24361963
[TBL] [Abstract][Full Text] [Related]
35. [Effects of allitridin on transcription of immediate-early, early and late genes of human cytomegalovirus in vitro].
Zhang J; Xiang Z; Liu X; Wang H; Li G; Fang F
Zhongguo Zhong Yao Za Zhi; 2011 Jul; 36(14):1988-92. PubMed ID: 22016974
[TBL] [Abstract][Full Text] [Related]
36. Quantitation of human cytomegalovirus DNA in peripheral blood leukocytes of heart transplant recipients: relationship with pp65 antigenemia and with antiviral therapy.
Barbui A; Pittaluga F; Donegani E; Bobbio M; di Summa M; Marchiaro G
Clin Microbiol Infect; 1999 Jan; 5(1):23-31. PubMed ID: 11856209
[TBL] [Abstract][Full Text] [Related]
37. Protein and DNA evidences of HCMV infection in primary breast cancer tissues and metastatic sentinel lymph nodes.
Cui J; Wang Q; Wang HB; Wang B; Li L
Cancer Biomark; 2018; 21(4):769-780. PubMed ID: 29286917
[TBL] [Abstract][Full Text] [Related]
38. Human cytomegalovirus (HCMV) infection in paediatric patients given allogeneic bone marrow transplantation: role of early antiviral treatment for HCMV antigenaemia on patients' outcome.
Locatelli F; Percivalle E; Comoli P; Maccario R; Zecca M; Giorgiani G; De Stefano P; Gerna G
Br J Haematol; 1994 Sep; 88(1):64-71. PubMed ID: 7803258
[TBL] [Abstract][Full Text] [Related]
39. In vitro co-infection by cytomegalovirus improves the antiviral activity of ganciclovir against human adenovirus.
Aguilar-Guisado M; Marrugal-Lorenzo JA; Berastegui-Cabrera J; Merino L; Pachón J; Sánchez-Céspedes J
Int J Antimicrob Agents; 2020 Aug; 56(2):106046. PubMed ID: 32540429
[TBL] [Abstract][Full Text] [Related]
40. Effects of PHA-665752 and Cetuximab Combination Treatment on In Vitro and Murine Xenograft Growth of Human Colorectal Cancer Cells with KRAS or BRAF Mutations.
Jia YT; Yang DH; Zhao Z; Bi XH; Han WH; Feng B; Zhi J; Gu B; Duan Z; Wu JH; Ju YC; Wang MX; Li ZX
Curr Cancer Drug Targets; 2018; 18(3):278-286. PubMed ID: 28359236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
